Form 4: Humana Director Kurt J. Hilzinger Reports Stock Unit Transactions

Director Kurt J. Hilzinger of Humana Inc. reports the acquisition of restricted stock units through deferred compensation and dividend reinvestment.

Summary

• Kurt J. Hilzinger, a director at Humana Inc., reported several transactions involving restricted stock units.
• These transactions include the acquisition of 783 restricted stock units as part of his annual director's fee, which are deferred until his resignation.
• Additionally, 565 stock units were acquired through the reinvestment of director's dividend payments.
• A further 673 stock units were acquired by converting cash fees into stock units.
• All stock units are deferred until his resignation and will be payable in Humana Inc. common stock on a 1-for-1 basis.

Sentiment

Score: 7

Explanation: The document reflects standard director compensation practices and does not indicate any unusual or concerning activity. The sentiment is neutral to slightly positive due to the alignment of interests.

Positives

• The acquisition of stock units demonstrates a continued alignment of interest between the director and the company's performance.
• The deferral of stock units until resignation may encourage long-term commitment from the director.

Future Outlook

The stock units will be converted to common stock on a 1-for-1 basis upon the director's resignation.

Industry Context

This filing is a routine disclosure of stock transactions by a company director, which is common practice in publicly traded companies.

Comparison to Industry Standards

• The use of restricted stock units as part of director compensation is a common practice among publicly traded companies.
• The deferral of these units until resignation is also a standard method to align director interests with long-term company performance.
• Many companies in the healthcare sector, such as UnitedHealth Group and CVS Health, also utilize similar compensation structures for their directors.

Stakeholder Impact

• The transactions have a minor positive impact on shareholders by aligning director interests with company performance.

Key Dates

Keywords

Humana, Director, Stock Units, Restricted Stock, Deferred Compensation, Dividend Reinvestment, Form 4, SEC Filing